23EL-890 On-Demand eCast: Stem Cell Tourism

Live Program Date: Wednesday, November 1, 2023
Program Number: 23EL-890

Educational Track: Scientific
Topics: Biotherapies
Intended Audience: Directors, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Perfusionists, Physicians, Research Scientists, Residents/Fellows, Scientists, Students (MD, MT, SBB), Technologists
Teaching Level: Basic, Intermediate

Faculty
(titles and affiliations at the time of the live program)
Director: Indira Guleria, PhD Diplomate (ABHI), CABP(H), Director, Histocompatibility and Immunogenetics (HLA), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
Moderator: Tom Spitzer, MD, Director Emeritus, Bone Marrow Transplant Program, Professor of Medicine, Harvard Medical School, Massachusetts General Hospital & Harvard Medical School, Boston, MA
Speakers: Indira Guleria, PhD Diplomate (ABHI), CABP(H), Director, Histocompatibility and Immunogenetics (HLA), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Maria De Los Angeles Muniz, MD, Assistant Professor, Department of Pathology and Laboratory Medicine, Transfusion Medicine, Cellular Therapy & Donor Center Division, RWJ Barnabas Health | Robert Wood Johnson University Hospital, New Brunswick, NJ

Program Description
Unproven cellular therapies are being offered to patients for a variety of conditions and diseases for which other treatments have failed. The practitioners are not fully aware of the risks involved with such therapies. A need therefore exists to bring attention to the potential limitations and adverse effects of these therapies to inform and limit misinformation. In this program, the faculty will discuss some of these cautionary tales and key adverse events associated with unproven cellular therapies as they relate to various disease conditions. A workflow to facilitate an understanding of the regulatory processes involved in the approval of cellular therapies will also be provided to educate the practitioners. This will provide practitioners a foundation and tools to further navigate the field of unproven cellular therapy products.

Learning Objectives
After participating in this educational activity, participants should be able to:

• Describe the concept of stem cell tourism/unproven cellular therapy and understand current trends and the role of social media in spread of unproven therapies across the globe.
• Realize issues and risk factors involved in the usage of unproven stem cell therapies.
• Recognize the regulatory, legislative, and ethical issues associated with unregulated stem cell therapies being used across different countries.

How to Claim Continuing Education Credit

• Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.

• Group Viewers: This is applicable for groups/facilities that purchased Group Viewing access for this program (registration will be verified prior to processing a group viewing attendance log). Group Viewing Coordinators should submit the attendance log to eLearning@aabb.org within 72 hours of the completion/viewing date. Once AABB receives an attendance log, each participant on the attendance log will be granted access as a single viewer to this program and will be required to complete the evaluation in order to claim continuing education credit. Each participant will be required to have an AABB account in order to access this program/platform. If a participant does not have an account, he/she can create one using the same email address provided on the attendance log.